Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ermenegildo Zegna NV
ZGN
5
Workday
WDAY
US OptionsDetailed Quotes
ARDX250516P3000
- 0.00
- 0.000.00%
15min DelayTrading May 8 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover0.00%IV19.57%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma37.30Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ardelyx Newsroom
Ardelyx First Quarter 2025 Earnings: Misses Expectations
Ardelyx Presents Data Supporting IBSRELA (Tenapanor) at Digestive Disease Week 2025 Conference
Ardelyx Insider Bought Shares Worth $1,610,936, According to a Recent SEC Filing
Ardelyx's Strong Commercial Execution and Growth Prospects Support Buy Rating Despite Challenges
Analysts Offer Insights on Healthcare Companies: Ardelyx (ARDX) and Twist Bioscience (TWST)
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Analysts Have Been Trimming Their Ardelyx, Inc. (NASDAQ:ARDX) Price Target After Its Latest Report
Ardelyx Analyst Ratings
Citi Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $10
Scotiabank Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $15
BTIG Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $14
12 Health Care Stocks Moving In Friday's Intraday Session
Ardelyx Downgraded at Raymond James After Q1 Sales Miss
Ardelyx ARDX Earnings; CytoSorbents CTSO Denied De Novo
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Arvinas Holding Company (ARVN) and Ardelyx (ARDX)
Raymond James Downgrades Ardelyx to Outperform From Strong Buy, Adjusts Price Target to $11 From $13
Scotiabank Remains a Buy on Ardelyx (ARDX)
Express News | Ardelyx Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results
Ardelyx Price Target Lowered to $10 From $11 at Citi
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now